Obama will be looking to pressure health care companies to deliver cheaper products to the US Government. This made equities trade lower in the US yesterday and Europe will follow
|Economic Data Releases|
|EC||E-Z CPI YoY (Jan)||10:00||1.1%||1.6%|
|US||GDP QoQ (annualized)||13:30||-5.4%||-3.8%|
|US||University of Michigan Confidence (FEB)||15:00||56.0||56.2|
What's going on?
European banks sector in trouble; are about to receive 24.5 bln. EUR in loans from World Bank, EBRD and EIB.
Japanese industrial production falls by record 10%; Japan is moving closer to a deeper recession as consumer spending abroad pummels the country's exports. Exports dropped by record 45.7%
|EURUSD||0/+||1.2790-10 res looks solid. Buy break above else we range-trade 1.2660-1.2780.|
|EURJPY||0/-||126.0 looks to cap for now, risks deeper correction to 122.00 level.|
|USDJPY||0||May have seen temp peak at 98.70. Failure to regain 98.0 handle risks 96.30-35.|
|GBPUSD||0||Ranging 1.4250-1.4380. Buy break above for 1.4450-70.|
|AUDUSD||0/+||Losses likely limited to 0.6400 suppt. Buy dips for push through 0.6500 for 0.6550-0.6600.|
|DAX||-||Sell at the break of 3912 targeting 3846 initially, 3790 finally. S/L at 3975.|
|FTSE||-||Sell at the break of 3875 targeting 3817 initially, 3772 finally. S/L at 3900.|
|S&P500||-||Sell at the break of 738 targeting 700. S/L 750.|
|Gold (XAUUSD)||0/-||Break through 950.0 indicates further weakness. Res 950.0 with med-term tgt still 850.0.|
|Silver (XAGUSD)||0/-||Squeezing lower. Seen pushing through 13.0 for 12.80.|
|Oil (CLJ9)||+||Current bull run seen extending to 45.70 res, then 48.0. Suppt at 41.50.|
|EURUSD||Vols moved lower generally, with the curve flattening as spot stayed in range. Gamma should see offers today if spot fails to break any new ground.|
|AUDUSD||Curve remains unchanged today with some interests selling short date strangles 6790 and 6250 strikes for early March so spot should be kept in range in the short term.|
|USDJPY||Front end gamma became quickly bid after the opening as spot broke under 98 and the rest of the curve followed higher. 98 level for NY cut should be in play today.|
Analysis Disclosure & Disclaimer
Saxo Bank A/S shall not be responsible for any loss arising from any investment based on any recommendation, forecast or other information herein contained. The contents of this publication should not be construed as an express or implied promise, guarantee or implication by Saxo Bank that clients will profit from the strategies herein or that losses in connection therewith can or will be limited. Trades in accordance with the recommendations in an analysis, especially leveraged investments such as foreign exchange trading and investment in derivatives, can be very speculative and may result in losses as well as profits, in particular if the conditions mentioned in the analysis do not occur as anticipated.
Saxo Bank utilizes financial information providers and information from such providers may form the basis for an analysis. Saxo Bank accepts no responsibility for the accuracy or completeness of any information herein contained.
Any recommendations and other comments in Saxo Bank's analysis derive from objective fundamental macro economical and company specific calculations, statistical and technical analysis, and subjective general market assessment.
If an analysis contains recommendations to buy or sell a specific financial instrument, such recommendation should be seen as Saxo Bank's opinion that the specific instrument will respectively outperform the relevant market or underperform compared to the market. Saxo Bank's recommendations should statistically correspond to an even distribution between buy and sell recommendations.
The recommendations may expire promptly due to market volatility and in general, Saxo Bank does not anticipate its recommendations to be valid more than one month. An analysis will be updated if and only if a market development or other issues relevant to the analysis render a new analysis on the same topic relevant. Saxo Bank's analysis does not cover any specific financial product over time but only products which Saxo Bank's strategy team finds it important to cover at any given point in time.
In order to prevent conflicts of interest, Saxo Bank has established appropriate business procedures, incl. procedures applicable to research and analysis to ensure objective research reports. Saxo Bank's research reports have not been discussed with the parties, e.g. issuers of securities, mentioned in the analysis.
Saxo Bank is under supervision by the Danish Financial Supervisory Authority. Saxo Bank does not engage in corporate finance activities and accordingly, Saxo Bank's employees, incl. the persons responsible for an analysis, do not receive remuneration associated with investment banking transactions.